ECO ANIMAL HEALTH GROUP PLC

Declaration of Voting Results & Voting Rights Announcements • Sep 26, 2022

National Storage Mechanism | Additional information

RNS Number : 6876A

Eco Animal Health Group PLC

26 September 2022

26 September 2022

ECO Animal Health Group plc ("the Company")

(AIM: EAH)

Result of Annual General Meeting

ECO Animal Health Group plc announces that at its Annual General Meeting held earlier today ("AGM") all resolutions proposed to the meeting were duly passed.

Proxy votes received in relation to each resolution were as follows:

Resolution	For	%	Discretionary	%	Against	%	Withheld
01	41,113,787	86.2178	30,535	0.0640	6,541,662	13.7182	Nil
02	47,645,198	99.9354	30,535	0.0640	251	0.0005	10,000
03	47,655,198	99.9354	30,535	0.0640	251	0.0005	Nil
04	47,632,825	99.8885	30,535	0.0640	22,624	0.0474	Nil
05	40,913,787	85.7983	19,007	0.0398	6,753,190	14.1618	Nil
06	47,644,711	99.9139	30,535	0.0640	10,487	0.0219	251
07	47,646,815	99.9304	30,535	0.0640	2,633	0.0055	6,001
08	47,642,165	99.9102	30,535	0.0640	12,283	0.0258	1,001

Contacts:

ECO Animal Health Group plc David Hallas (CEO) Christopher Wilks (CFO)	020 8447 8899
IFC Advisory Graham Herring Zach Cohen	020 3934 6630
Singer Capital Markets (Nominated Adviser & Joint Broker) Mark Taylor George Tzimas	020 7496 3000
Investec (Joint Broker) Gary Clarence Brough Ransom Carlo Spingardi	020 7597 5970
Peel Hunt LLP (Joint Broker) Dr Christopher Golden	020 7418 8900

James Steel

Equity Development Hannah Crowe Matt Evans	020 7065 2692

About ECO Animal Health

ECO Animal Health Group plc researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGSESFIMEESESU